TYMS and malignant pleural mesothelioma: Raltitrexed is a quinazoline inhibitor of the enzyme thymidylate synthase and it is employed in the treatment of advanced malignant pleural mesothelioma [in association with cisplatin it has been demonstrated to improve the overall survival (41)] and in the treatment of advanced colorectal cancer.